Uncovering Answers to Protect Patients' Health
Boehringer Ingelheim has a large and experienced global team managing and conducting clinical trials in many indications. During the past decade, 1,223 studies with 125 substances were conducted or sponsored. These studies enrolled approximately 1.2 million patients. The study centres are located in 58 countries all over the world.
Basic Information
Boehringer Ingelheim conducts and sponsors clinical trials to establish safety and efficacy of the drugs we develop, either for use in their initial indication or in additional indications.
